IL6 and COVID-19: The GSH precursor N-acetylcysteine (NAC) has anti-ferroptotic effects via the direct reinforcement of the cystine–GSH–GPX4 axis and the reduction of IL-6-induced ROS production [106], which is related to its efficiency in treating COVID-19.